Cytochrome P450 3A pharmacogenetics: the road that needs traveled

[1] POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN AND OMEPRAZOLE METABOLISM IN CAUCASIAN AND CHINESE SUBJECTS [J]. PHARMACOGENETICS, 1992, 2 (01): : 25 - 31

[2] Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 288 - 294

[3] INHIBITION BY PAROXETINE OF DESIPRAMINE METABOLISM IN EXTENSIVE BUT NOT IN POOR METABOLIZERS OF SPARTEINE [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) : 349 - 355

[4] Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 24280 - 24288

[5] Caraco Y, 1999, J PHARMACOL EXP THER, V290, P413

[6] 10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CΥP2D6 genes [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (04) : 444 - 452

[7] Identification and functional characterization of eight CYP3A4 protein variants [J]. PHARMACOGENETICS, 2001, 11 (05): : 447 - 458

[8] Association of CYP3A4 genotype with treatment-related leukemia [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13176 - 13181

[9] The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons [J]. GENE, 2000, 260 (1-2) : 13 - 23

[10] Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) : 1027 - 1030

[1] POLYMORPHIC HYDROXYLATION OF S-MEPHENYTOIN AND OMEPRAZOLE METABOLISM IN CAUCASIAN AND CHINESE SUBJECTS [J]. PHARMACOGENETICS, 1992, 2 (01): : 25 - 31

[2] Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) : 288 - 294

[3] INHIBITION BY PAROXETINE OF DESIPRAMINE METABOLISM IN EXTENSIVE BUT NOT IN POOR METABOLIZERS OF SPARTEINE [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) : 349 - 355

[4] Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) : 24280 - 24288

[5] Caraco Y, 1999, J PHARMACOL EXP THER, V290, P413

[6] 10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CΥP2D6 genes [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (04) : 444 - 452

[7] Identification and functional characterization of eight CYP3A4 protein variants [J]. PHARMACOGENETICS, 2001, 11 (05): : 447 - 458

[8] Association of CYP3A4 genotype with treatment-related leukemia [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13176 - 13181

[9] The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons [J]. GENE, 2000, 260 (1-2) : 13 - 23

[10] Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) : 1027 - 1030